New England Peptide

NEP is specialized in peptide and antibody custom synthesis and catalog products used in research & development by our clients in the life science sector.

[New England Peptide @NEPeptide]

New year, new name, continuous commitment to science!

We are delighted to announce that we are changing our name from New England Peptide to vivitide. @vivitideScience

https://t.co/uhtxXQzk58

[Biosynth @BiosynthGroup]

For #toxinTuesday, a hopeful potential for travel & junior #scientists

[New England Peptide @NEPeptide]

Doudna Talks #Nobel Success and #womeninscience https://t.co/J3GAQG9hM2 via @GENbio

[New England Peptide @NEPeptide]

@PeptidesIntl These are the very final days of our Thank You Sale.
All new catalog orders are discounted 10%. This includes #peptides, #proteins, #inhibitors & #substrates, & even #COVID19 research items!
https://t.co/3yozQONVy3

#diabetes, #Alzheimers, #autoimmune #drugdiscovery #toxinTusday

[Denise K @ChemistryDenise]

Recently, I made a switch from research peptides to GMP peptides. I am delighted to stay in the peptide world and reunite with some former colleagues
@Ambio_peptides

[Biosynth @BiosynthGroup]

Vol 32, Issue 19 of the PEPNET E-Newsletter: "6 Exciting New Products Released + Final Weeks of Our Catalog Sale" - A 1st look at just-added items w/a range of #research applications, plenty of #COVID19 & #peptide news articles, & much more!

https://t.co/ULgIKXChia

[Denise K @ChemistryDenise]

Happy #ToxinTuesday

[Biosynth @BiosynthGroup]

For #toxinTuesday, here's a reminder that all of our high-quality #peptide #toxins are discounted from now until the end of the year - along with every one of our other catalog items!

https://t.co/4VTsNTa1bT

[New England Peptide @NEPeptide]

We came across this interesting article, after we posted our #Alzheimer’s Disease Spotlight.

Remember all of our AD products are on sale this month too!
https://t.co/jNGBUDzOPM

Pathway Identified as Potential Early Therapeutic Target https://t.co/Bq1ivGIl1F via @GENbio

[Biosynth @BiosynthGroup]

@NEPeptide | @PeptidesIntl are acknowledged for their quality, support, & integrity!

[Martina Diekmann @MartinaDiekmann]

I’m very excited to announce that Ehab Alramahy is joining us as Vice President, Global Marketing & Sales. Ehab has significant experience in Peptide Contract Manufacturing gained in several leadership roles in Europe and North America
#welcometotheteam @NEPeptide @PeptidesIntl

[New England Peptide @NEPeptide]

We REALLY appreciate the endorsment for our #peptides @X0S0ME !

[Biosynth @BiosynthGroup]

The World #Vaccine & #Immunotherapy Congress West Coast 2020 is going on today & tomorrow! We're attending & would love to discuss how we can assist w/your #research!

https://t.co/TuJst8Tlhy
https://t.co/D6jbLQqxRd
https://t.co/UUfqHmVgfT
@Terrapinn #antibodies #peptides

[World Health Organization (WHO) @WHO]

Today is #WorldAIDSDay!

Take a moment to thank community health workers, nurses, doctors, scientists & everybody involved in the fight against #HIV around 🌎🌍🌏.

They are at the forefront playing a 🗝️ part in supporting people living with HIV & helping to end AIDS.

[New England Peptide @NEPeptide]

All of our catalog products are ON SALE! Simply mention "Thanksgiving2020" when ordering. This includes #research areas such as: #coronavirus, #diabetes, #Alzheimers, and many others!

https://t.co/D6qSLEWieV

#peptides #drugdiscovery

[Biosynth @BiosynthGroup]

Starting today: all of our catalog products are ON SALE! Simply mention "Thanksgiving2020" when ordering. This includes #research areas such as: #coronavirus, #diabetes, #Alzheimers, and many others!

https://t.co/UUfqHmVgfT

#peptides #drugdiscovery

[Biosynth @BiosynthGroup]

World Vaccine & Immunotherapy Congress West Coast 2020 | 1 - 3 December 2020
https://t.co/o8aCU8stGQ
Attending the World #Vaccine & #Immunotherapy Congress West Coast? Meet our brand new west coast sales rep, & hear how we can assist you w/ your #research for #vaccinedevelopment!

[Glenn King @VenomsLab]

Loss-of-function mutations in the gene encoding the Nav.7 #IonChannel lead to a congenital inability to experience #pain. Yet potent Nav1.7 inhibitors have failed as #analgesics in #ClinicalTrials. We discuss why in this new review in @BrJPharmacol https://t.co/z98w0DFW6o